An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer
暂无分享,去创建一个
X. Shirley Liu | Hyunjin Shin | Shuji Ogino | Barbara A. Weir | William C. Hahn | Francisca Vazquez | Adam J. Bass | Zhi Rong Qian | Ramesh A. Shivdasani | Fergal Casey | W. Hahn | B. Weir | X. Liu | A. Bass | Vivien W. Chan | F. Vazquez | Hyunjin Shin | S. Ogino | Z. Qian | R. Shivdasani | Rita Sulahian | Rita Sulahian | Jill Shen | Vivien Chan | Fergal Casey | J. Shen | X. Liu | X. Liu
[1] X. Shirley Liu,et al. Essential and Redundant Functions of Caudal Family Proteins in Activating Adult Intestinal Genes , 2011, Molecular and Cellular Biology.
[2] Ryoichiro Kageyama,et al. The Hes gene family: repressors and oscillators that orchestrate embryogenesis , 2007, Development.
[3] A. Matsuda,et al. Trends in stomach cancer mortality rates in Japan, USA, UK, France and Korea based on the WHO mortality database. , 2012, Japanese journal of clinical oncology.
[4] T. Golub,et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.
[5] Hans Clevers,et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. , 2010, Cell stem cell.
[6] Khay Guan Yeoh,et al. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets , 2012, Gut.
[7] L. Olds,et al. Spatio-temporal patterns of intestine-specific transcription factor expression during postnatal mouse gut development. , 2006, Gene expression patterns : GEP.
[8] Benjamin J Bondow,et al. Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. , 2008, Developmental biology.
[9] D. Botstein,et al. Variation in gene expression patterns in human gastric cancers. , 2003, Molecular biology of the cell.
[10] M. Futai,et al. Gastric DNA-binding proteins recognize upstream sequence motifs of parietal cell-specific genes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[11] Jorma Isola,et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.
[12] J. Mesirov,et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer , 2011, Proceedings of the National Academy of Sciences.
[13] D. Cunningham,et al. Targeting the human EGFR family in esophagogastric cancer , 2011, Nature Reviews Clinical Oncology.
[14] Reid F. Thompson,et al. Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis , 2011, PLoS genetics.
[15] R. Shivdasani,et al. Notch signaling in stomach epithelial stem cell homeostasis , 2011, The Journal of experimental medicine.
[16] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[17] J. G. Park,et al. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. , 2001, Cancer research.
[18] R. Lucito,et al. Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma , 2008, Cancer biology & therapy.
[19] D. Frank. Targeting transcription factors for cancer therapy. , 2008, IDrugs : the investigational drugs journal.
[20] C. Mueller,et al. GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. , 1994, The Journal of biological chemistry.
[21] T. Hirao,et al. The prognostic significance of amplification and overexpression of c‐met and c‐erb B‐2 in human gastric carcinomas , 1999, Cancer.
[22] R. Playford,et al. Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] Ernest Fraenkel,et al. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. , 2009, Molecular cell.
[24] Clifford A. Meyer,et al. Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. , 2010, Developmental cell.
[25] M. Meyerson,et al. Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma , 2012, Proceedings of the National Academy of Sciences.
[26] M. van de Rijn,et al. Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer , 2008, PLoS genetics.
[27] M. Meyerson,et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. , 2012, Cancer research.
[28] Cem Elbi,et al. FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival. , 2008, Cancer research.
[29] Yuriy L Orlov,et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. , 2010, Cell stem cell.
[30] Elaine Dzierzak,et al. Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling , 2013, The Journal of experimental medicine.
[31] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[32] Manolis Kellis,et al. Whole-genome ChIP-chip analysis of Dorsal, Twist, and Snail suggests integration of diverse patterning processes in the Drosophila embryo. , 2007, Genes & development.
[33] Jeffrey W. Clark,et al. MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] Clifford A. Meyer,et al. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. , 2008, Genome research.
[35] J. Darnell. Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.
[36] Heng Tao Shen,et al. Principal Component Analysis , 2009, Encyclopedia of Biometrics.
[37] A. Regev,et al. SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.
[38] C. Allis,et al. Extraction, purification and analysis of histones , 2007, Nature Protocols.
[39] Hao Wang,et al. Global regulation of erythroid gene expression by transcription factor GATA-1. , 2004, Blood.
[40] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[41] Yunbo Shi,et al. Distinct Functions Are Implicated for the GATA-4, -5, and -6 Transcription Factors in the Regulation of Intestine Epithelial Cell Differentiation , 1998, Molecular and Cellular Biology.
[42] E. Bresnick,et al. GATA-1 Utilizes Ikaros and Polycomb Repressive Complex 2 To Suppress Hes1 and To Promote Erythropoiesis , 2012, Molecular and Cellular Biology.
[43] Clifford A. Meyer,et al. Cistrome: an integrative platform for transcriptional regulation studies , 2011, Genome Biology.
[44] H. Clevers,et al. Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.
[45] S. Duncan,et al. GATA factors regulate proliferation, differentiation, and gene expression in small intestine of mature mice. , 2011, Gastroenterology.
[46] T. Evans,et al. Gata4 regulates the formation of multiple organs , 2005, Development.
[47] Derek Y. Chiang,et al. Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.
[48] R. Poulsom,et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[49] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.